A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Considerations

Yongquan Tang1, Yan Chen2, Hai-Ning Chen3

  • 1Department of Pediatric Surgery, West China Hospital, Sichuan University, Chengdu, China; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.

Journal of Hepatology
|June 11, 2022
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos